Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.19 USD
-0.01 (-5.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Gritstone bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -138.49 | -119.69 | -75.08 | -105.31 | -94.43 |
Depreciation/Amortization & Depletion | 6.31 | 6.58 | 7.16 | 6.52 | 3.40 |
Net Change from Assets/Liabilities | -17.14 | -24.53 | -1.36 | -4.93 | -5.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 27.67 | 21.69 | 18.60 | 14.62 | 11.68 |
Net Cash From Operating Activities | -121.65 | -115.95 | -50.68 | -89.10 | -85.01 |
Property & Equipment | -4.57 | -5.87 | -5.46 | -3.52 | -16.17 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 106.91 | -7.09 | -112.85 | 69.46 | 32.01 |
Other Investing Activities | 0.00 | 0.00 | -0.24 | 0.00 | 0.00 |
Net Cash from Investing Activities | 102.34 | -12.96 | -118.55 | 65.95 | 15.84 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 8.93 | 65.51 | 117.21 | 135.91 | 75.20 |
Issuance (Repayment) of Debt | 19.68 | 18.90 | -0.06 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.49 | -1.31 | -8.39 | -0.10 | -0.81 |
Net Cash from Financing Activities | 25.12 | 83.10 | 108.76 | 135.80 | 74.40 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 5.81 | -45.81 | -60.47 | 112.65 | 5.23 |
Cash at Beginning of Period | 64.77 | 110.58 | 171.05 | 58.40 | 53.18 |
Cash at End of Period | 70.58 | 64.77 | 110.58 | 171.05 | 58.40 |
Diluted Net EPS | -1.20 | -1.32 | -0.95 | -2.79 | -2.81 |
Fiscal Year End for Gritstone bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -63.78 | -40.39 | -138.49 | -107.67 | -69.24 |
Depreciation/Amortization & Depletion | 3.99 | 2.06 | 6.31 | 4.22 | 2.55 |
Net Change from Assets/Liabilities | -10.60 | -3.28 | -17.14 | -17.78 | -16.98 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 10.01 | 8.04 | 27.67 | 19.10 | 12.61 |
Net Cash From Operating Activities | -60.38 | -33.57 | -121.65 | -102.14 | -71.05 |
Property & Equipment | -0.18 | -0.14 | -4.57 | -4.38 | -3.29 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 11.59 | 12.45 | 106.91 | 68.43 | 49.05 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 11.42 | 12.30 | 102.34 | 64.05 | 45.77 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 38.38 | 0.05 | 8.93 | 3.08 | 3.06 |
Issuance (Repayment) of Debt | -0.12 | -0.06 | 19.68 | 9.78 | 9.84 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.00 | -0.36 | -3.49 | -3.46 | -3.24 |
Net Cash from Financing Activities | 35.25 | -0.38 | 25.12 | 9.40 | 9.66 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -13.71 | -21.64 | 5.81 | -28.69 | -15.62 |
Cash at Beginning of Period | 70.58 | 70.58 | 64.77 | 64.77 | 64.77 |
Cash at End of Period | 56.87 | 48.93 | 70.58 | 36.07 | 49.14 |
Diluted Net EPS | -0.16 | -0.34 | -0.26 | -0.33 | -0.31 |